Sight Sciences (SGHT) EBT Margin (2020 - 2026)
Sight Sciences' (SGHT) quarterly EBT Margin came in at 65.84% in Q1 2026, up 1477.0% year-on-year from 4.17% in Q1 2025, and down 223.09% quarter-over-quarter from 20.38% in Q4 2025.
Sight Sciences (SGHT) EBT Margin (2020 - 2026) Analysis & Trends
Sight Sciences' EBT Margin history runs 7 years deep, the most recent figure standing at 65.84% for Q1 2026.
- On a quarterly basis, EBT Margin rose 1477.0% year-over-year to 65.84% in Q1 2026; TTM through Mar 2026 was 46.85%, a 1605.0% increase from a year earlier, with the FY2025 full-year figure at 49.66%, up 1454.0% from the prior year.
- EBT Margin declined to 65.84% in Q1 2026 per SGHT's latest filing, from 20.38% in the prior quarter.
- Across five years, EBT Margin topped out at 20.38% in Q4 2025 and bottomed at 156.27% in Q1 2022.
- The 5-year median for EBT Margin is 64.76% (2023), against an average of 76.35%.
- Across the five-year window, EBT Margin slumped 1512 bps in 2022 and jumped 7551 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 82.25% in 2022, then surged by 31 bps to 56.96% in 2023, then retreated by 9 bps to 61.91% in 2024, then surged by 67 bps to 20.38% in 2025, then sank by 223 bps to 65.84% in 2026.
- Per Business Quant, the three latest SGHT EBT Margin figures stand at 65.84% (Q1 2026), 20.38% (Q4 2025), and 41.43% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | -65.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.84% |
| Dec 31, 2025 | -20.38% |
| Sep 30, 2025 | -41.43% |
| Jun 30, 2025 | -60.83% |
| Mar 31, 2025 | -80.61% |
| Dec 31, 2024 | -61.91% |
| Sep 30, 2024 | -54.08% |
| Jun 30, 2024 | -57.62% |
| Mar 31, 2024 | -84.34% |
| Dec 31, 2023 | -56.96% |
| Sep 30, 2023 | -64.76% |
| Jun 30, 2023 | -62.83% |
| Mar 31, 2023 | -90.59% |
| Dec 31, 2022 | -82.25% |
| Sep 30, 2022 | -118.92% |
| Jun 30, 2022 | -138.34% |
| Mar 31, 2022 | -156.27% |
| Dec 31, 2021 | -107.85% |
| Sep 30, 2021 | -130.93% |
| Jun 30, 2021 | -140.35% |